imatinib mesylate has been researched along with Bullous Dermatoses in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dogra, S; Handa, S; Khadwal, A; Kumari, S; Lad, D; Malhotra, P; Prakash, G; Suri, V; Varma, S; Vinay, K; Yanamandra, U | 1 |
| Esturo, SV; Moreno, AJ; Pérez, NO; Valls, AT; Viladomiu, Edel A | 1 |
| Neoh, CY; Ng, SK; Tan, AW | 1 |
3 other study(ies) available for imatinib mesylate and Bullous Dermatoses
| Article | Year |
|---|---|
Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Cross-Sectional Studies; Drug Eruptions; Edema; Eye Diseases; Female; Humans; Hyperpigmentation; Hypopigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Nail Diseases; Sex Factors; Skin Diseases, Vesiculobullous; Time Factors; Young Adult | 2018 |
Pseudoporphyria induced by imatinib mesylate.
Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Hand Dermatoses; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Porphyrins; Pyrimidines; Skin Diseases, Vesiculobullous | 2014 |
Sweet's syndrome: a spectrum of unusual clinical presentations and associations.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Female; Hand Dermatoses; Hematologic Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neutrophils; Piperazines; Pyrimidines; Retrospective Studies; Skin Diseases, Vesiculobullous; Sweet Syndrome | 2007 |